A standardized definition of ischemic cardiomyopathy for use in clinical research.
about
To Revascularise or Not To Revascularise, That Is the Question: the Diagnostic and Management Conundrum of Ischaemic CardiomyopathyNew Insights in the Diagnosis and Treatment of Heart FailureAcute effects of outdoor air pollution on emergency department visits due to five clinical subtypes of coronary heart diseases in shanghai, chinaSurgical ventricular reconstruction for ischaemic heart failure: state of the art.Gene expression patterns in peripheral blood correlate with the extent of coronary artery disease.Two-transcript gene expression classifiers in the diagnosis and prognosis of human diseases.NCAM(CD56) and RUNX1(AML1) are up-regulated in human ischemic cardiomyopathy and a rat model of chronic cardiac ischemia.Establishment of a novel murine model of ischemic cardiomyopathy with multiple diffuse coronary lesions.Influence of Angiotensin-Converting-Enzyme Gene Polymorphism on Echocardiographic Data of Patients with Ischemic Heart Failure.GATA2 is associated with familial early-onset coronary artery disease.Genetic and functional association of FAM5C with myocardial infarctionMolecular remodeling of ion channels, exchangers and pumps in atrial and ventricular myocytes in ischemic cardiomyopathy.Computational method for identifying and quantifying shape features of human left ventricular remodeling.Decreased cardiac mortality with nicorandil in patients with ischemic heart failurePilot study using 3D-longitudinal strain computation in a multi-parametric approach for best selecting responders to cardiac resynchronization therapy.Aging-related atherosclerosis is exacerbated by arterial expression of tumor necrosis factor receptor-1: evidence from mouse models and human association studies.Extent of coronary and myocardial disease and benefit from surgical revascularization in ischemic LV dysfunction [Corrected].Quantifying late gadolinium enhancement on CMR provides additional prognostic information in early risk-stratification of nonischemic cardiomyopathy: a cohort study.Coronary artery disease, coronary revascularization, and outcomes in chronic advanced systolic heart failure.Influence of documented history of coronary artery disease on outcomes in patients admitted for worsening heart failure with reduced ejection fraction in the EVEREST trial.New vessel formation in the context of cardiomyocyte regeneration--the role and importance of an adequate perfusing vasculature.Prognostic value of contrast-enhanced cardiac magnetic resonance imaging in patients with newly diagnosed non-ischemic cardiomyopathy: cohort study.Ischemic cardiomyopathy is associated with coronary plaque progression and higher event rate in patients after cardiac transplantationClinical applications of cardiovascular magnetic resonance imagingPeakwide mapping on chromosome 3q13 identifies the kalirin gene as a novel candidate gene for coronary artery disease.Myocardial viability and survival in ischemic left ventricular dysfunction.Burden of Comorbidities and Functional and Cognitive Impairments in Elderly Patients at the Initial Diagnosis of Heart Failure and Their Impact on Total Mortality: The Cardiovascular Health Study.Combined cardiac magnetic resonance imaging and C-reactive protein levels identify a cohort at low risk for defibrillator firings and deathUrinary Proteomics Pilot Study for Biomarker Discovery and Diagnosis in Heart Failure with Reduced Ejection Fraction.Diagnostic Accuracy of Cardiac Magnetic Resonance Imaging in the Evaluation of Newly Diagnosed Heart Failure With Reduced Left Ventricular Ejection Fraction.Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies.Quantification of coronary flow reserve in patients with ischaemic and non-ischaemic cardiomyopathy and its association with clinical outcomes.Chronic kidney disease and cardiac remodelling in patients with mild heart failure: results from the REsynchronization reVErses Remodeling in Systolic Left vEntricular Dysfunction (REVERSE) study.Concordant and Discordant Cardiac Magnetic Resonance Imaging Delayed Hyperenhancement Patterns in Patients with Ischemic and Non-Ischemic CardiomyopathyHeart failure in the twenty-first century: is it a coronary artery disease or hypertension problem?Prognostic Value of Pulmonary Vascular Resistance by Magnetic Resonance in Systolic Heart FailureLate gadolinium enhancement by cardiovascular magnetic resonance heralds an adverse prognosis in nonischemic cardiomyopathyCombined coronary and late-enhanced multidetector-computed tomography for delineation of the etiology of left ventricular dysfunction: comparison with coronary angiography and contrast-enhanced cardiac magnetic resonance imaging.Effects of the intramyocardial implantation of stromal vascular fraction in patients with chronic ischemic cardiomyopathyDysfunction of the β2-spectrin-based pathway in human heart failure.
P2860
Q26749674-D636C3A7-0D32-465C-82D5-C95097EE2F03Q26774884-FA562084-1C39-4139-830F-1C9A7ABDFB79Q28654207-AC7FCB4B-1D42-44AD-B37A-65978B0415C6Q30355935-CF43F84D-387B-4C59-AC93-0016C95918D1Q30486777-0B8679E1-CBF8-4AE7-BE02-CB55564EFDB1Q30955253-A51075CB-D45D-42F3-B2F9-B50C1AE6AD78Q30978186-063788C6-07C9-4888-A8AA-35216935735AQ31126526-1D77CB78-3061-42DF-B165-94509372FA44Q31140878-CF8D226C-D9C8-4992-A661-4F81BCCC51A8Q33255348-07A3083B-D37C-4EF1-86CA-2072B202183BQ33330164-F3808083-7578-41F4-93DF-3C3E4733DE63Q33525464-6FD7C098-B375-43E4-8180-10B298DD05E9Q33640624-DC385A6A-FF7F-4DB4-8F4A-2331E3409DD0Q33749769-C2D1B8C5-3786-427B-B472-AB893158AB32Q33808468-A362DF7A-C064-489E-8BEB-828ED84EB1A8Q33947816-904DE480-7B12-4817-A71A-AD0F1BD9F2C3Q34031313-39F59B8E-8F92-48A3-A95D-7CD69AF90538Q34130016-6D011444-9DDB-4077-B794-FB2E17B1D0BAQ34138645-DB58131B-9E7C-4D21-AB61-F4E29C620C50Q34248663-5D7BBF65-9034-456F-99AA-C40868FE6E92Q34422460-5335EAD4-C0B4-423D-B03E-E72E053F2813Q34600002-D2E2DDE2-F6CC-4570-B797-55991175BF70Q35026402-3CFE30E0-59D4-4D56-9D39-32CF571F8F1DQ35062046-EE7ECB04-75FD-4B19-9714-AC7DEAFD4DECQ35752509-5039D40C-093B-4BF6-B1B0-A8D773B95716Q35791994-597F13FB-3B8C-4814-8FA9-9AF5A714B333Q35842447-90826540-63A4-408B-8EB0-E268B15FFE8DQ35899984-7B9CE4FF-A5DC-40A9-97B6-F46C5613587AQ36053833-3A9DFF01-99BE-4A13-A8D8-40C293108C30Q36054409-37CF5137-970E-4C30-904C-67512BEF58B9Q36098649-52672F82-6C2D-43F3-AB82-834BC4716788Q36117344-48E41CD9-67A3-4281-BD98-9CD1D5B37704Q36424877-E771D86E-667B-45FF-BF0B-F8D509859E32Q36485009-447FBE23-D82F-480E-90E9-78FADF455BEEQ36596985-C9DBC4C8-5EEF-4504-B238-FB8C58A8328EQ36738249-6CA5C67A-F1F1-4A7B-9788-9BB821322F09Q36761955-44DFDDFD-DEC5-4FC3-A80A-EEC6C7293CDDQ36935868-A4DF3EBC-C273-4C2D-BC4F-D90C594F666AQ36960036-DB9DD2BE-5B9E-462C-8ED7-36C4AD4083FDQ37071936-7E5CD172-A202-4AC0-ADDF-0034FA77CEE8
P2860
A standardized definition of ischemic cardiomyopathy for use in clinical research.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
A standardized definition of ischemic cardiomyopathy for use in clinical research.
@en
A standardized definition of ischemic cardiomyopathy for use in clinical research.
@nl
type
label
A standardized definition of ischemic cardiomyopathy for use in clinical research.
@en
A standardized definition of ischemic cardiomyopathy for use in clinical research.
@nl
prefLabel
A standardized definition of ischemic cardiomyopathy for use in clinical research.
@en
A standardized definition of ischemic cardiomyopathy for use in clinical research.
@nl
P1476
A standardized definition of ischemic cardiomyopathy for use in clinical research.
@en
P2093
G Michael Felker
Linda K Shaw
P304
P356
10.1016/S0735-1097(01)01738-7
P407
P577
2002-01-01T00:00:00Z